Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The current conceptualization of negative symptoms in schizophrenia
Stephen R. Marder, Silvana Galderisi
World Psychiatry (2017) Vol. 16, Iss. 1, pp. 14-24
Open Access | Times Cited: 441

Showing 1-25 of 441 citing articles:

<p>Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment</p>
Christoph U. Correll, Nina R. Schooler
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 519-534
Open Access | Times Cited: 559
Negative symptoms of schizophrenia: new developments and unanswered research questions
Silvana Galderisi, Armida Mucci, Robert W. Buchanan, et al.
The Lancet Psychiatry (2018) Vol. 5, Iss. 8, pp. 664-677
Closed Access | Times Cited: 441
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Mario Maj, Jim van Os, Marc D. Binder, et al.
World Psychiatry (2021) Vol. 20, Iss. 1, pp. 4-33
Open Access | Times Cited: 226
Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
Marc Krause, Yikang Zhu, Maximilian Huhn, et al.
European Archives of Psychiatry and Clinical Neuroscience (2018) Vol. 268, Iss. 7, pp. 625-639
Open Access | Times Cited: 185
EPA guidance on assessment of negative symptoms in schizophrenia
Silvana Galderisi, Armida Mucci, Sonia Dollfus, et al.
European Psychiatry (2021) Vol. 64, Iss. 1
Open Access | Times Cited: 176
Neuroscience of Psychotherapy
Susan Vaughan, Mohsin Ahmed
American Psychiatric Association Publishing eBooks (2022)
Closed Access | Times Cited: 150
EPA guidance on treatment of negative symptoms in schizophrenia
Silvana Galderisi, Stefan Kaiser, István Bitter, et al.
European Psychiatry (2021) Vol. 64, Iss. 1
Open Access | Times Cited: 136
Primary and Secondary Negative Symptoms in Schizophrenia
Sergey Mosolov, Polina A. Yaltonskaya
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 72
The Latent Structure of Negative Symptoms in Schizophrenia
Gregory P. Strauss, Alicia Nuñez, Anthony O. Ahmed, et al.
JAMA Psychiatry (2018) Vol. 75, Iss. 12, pp. 1271-1271
Open Access | Times Cited: 160
Anhedonia in depression and schizophrenia: A transdiagnostic challenge
Clare Lambert, Susana Da Silva, Amanda K. Ceniti, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 7, pp. 615-623
Open Access | Times Cited: 129
Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia
Anthony O. Ahmed, Brian Kirkpatrick, Silvana Galderisi, et al.
Schizophrenia Bulletin (2018) Vol. 45, Iss. 2, pp. 305-314
Open Access | Times Cited: 122
Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia
Gregory P. Strauss, Farnaz Zamani Esfahlani, Silvana Galderisi, et al.
Schizophrenia Bulletin (2018) Vol. 45, Iss. 5, pp. 1033-1041
Open Access | Times Cited: 109
The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors
Wolfgang Fleischhacker, Silvana Galderisi, I. Laszlovszky, et al.
European Psychiatry (2019) Vol. 58, pp. 1-9
Open Access | Times Cited: 104
Primary, Enduring Negative Symptoms: An Update on Research
Brian Kirkpatrick, Armida Mucci, Silvana Galderisi
Schizophrenia Bulletin (2017) Vol. 43, Iss. 4, pp. 730-736
Open Access | Times Cited: 93
Pathophysiology of negative symptom dimensions of schizophrenia – Current developments and implications for treatment
Indrit Bègue, Stefan Kaiser, Matthias Kirschner
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 74-88
Open Access | Times Cited: 93
Autism spectrum disorder and schizophrenia: An updated conceptual review
Amandeep Jutla, Jennifer H. Foss‐Feig, Jeremy Veenstra‐VanderWeele
Autism Research (2021) Vol. 15, Iss. 3, pp. 384-412
Open Access | Times Cited: 89
Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights
Mansour Zamanpoor
Psychiatric Genetics (2019) Vol. 30, Iss. 1, pp. 1-9
Closed Access | Times Cited: 80
Generalizable brain network markers of major depressive disorder across multiple imaging sites
Ayumu Yamashita, Yuki Sakai, Takashi Yamada, et al.
PLoS Biology (2020) Vol. 18, Iss. 12, pp. e3000966-e3000966
Open Access | Times Cited: 72
Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
Gregory P. Strauss, Lisa A. Bartolomeo, Philip D. Harvey
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 67
Thirty years of research on negative symptoms of schizophrenia: A scientometric analysis of hotspots, bursts, and research trends
Michel Sabé, Chaomei Chen, Natacha Perez, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104979-104979
Open Access | Times Cited: 54
Speech disturbances in schizophrenia: Assessing cross-linguistic generalizability of NLP automated measures of coherence
Alberto Parola, Jessica Mary Lin, Arndis Simonsen, et al.
Schizophrenia Research (2022) Vol. 259, pp. 59-70
Open Access | Times Cited: 39
Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses
Matteo Cella, Safina Roberts, Matthias Pillny, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 321-331
Open Access | Times Cited: 39
A systematic review of EEG based automated schizophrenia classification through machine learning and deep learning
Jagdeep Rahul, Diksha Sharma, Lakhan Dev Sharma, et al.
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 14
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia
Giulia Maria Giordano, Pasquale Pezzella, Armida Mucci, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 10
Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia?
Martin Strassnig, Christopher R. Bowie, A.E. Pinkham, et al.
Journal of Psychiatric Research (2018) Vol. 104, pp. 124-129
Closed Access | Times Cited: 81
Page 1 - Next Page

Scroll to top